Top of this page
Skip navigation, go straight to the content
FAQs
Answers to our investors' frequently asked questions:
What is UCB's position with respect to the Corporate Governance principles?
As a Belgian-headquartered company with a commitment to the highest standards of corporate governance, UCB's Board of Directors adopted the Charter of Corporate Governance in October 2005, as required by the Belgian Code on Corporate Governance.
This Charter, which is available on our website, describes the main aspects of UCB's corporate governance, including its governance structure and the terms of reference of the Board of Directors, as well as those of its Committees and the Executive Committee.
Your questions our answers
- When was UCB founded?
- What are UCB main areas of activities?
- How many people does the new UCB employ?
- What are the group key figures?
- What are UCB's topselling products during the first half 2007?
- On which accounting standards are the consolidated financial statements of the UCB group based?
- How is the fiscal year defined?
- Does UCB reports quarterly?
- When will the next shareholders' meeting take place?
- Amount and date of the current dividend?
- What are the major shareholders of UCB?
- How many UCB shares are outstanding?
- Does UCB have ADR (American Depositary Receipt)?
- What is UCB's position with respect to the Corporate Governance principles?
- How can I order UCB annual reports?
- As a former Celltech shareholder, how can I return my shares to UCB?
- As a Schwarz Pharma shareholder, how and when can I return my shares to UCB SP GmbH?
